- PBLA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-1 Filing
Panbela Therapeutics (PBLA) S-12020 Q1 IPO registration
Filed: 2 Jul 20, 4:32pm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the reference to our firm under the caption “Experts” in this Registration Statement on Form S-1 and related prospectus of Sun BioPharma, Inc. and to the inclusion therein of our report, dated March 24, 2020, with respect to the consolidated financial statements of Sun BioPharma, Inc. appearing in its Form 10-K filed March 24, 2020 with the Securities and Exchange Commission.
/s/ Cherry Bekaert LLP
Tampa, Florida
July 2, 2020
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.